None listed
Conditions
Interventions
None listed
Sponsors
Samsung Medical Center
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1.1. Selection criteria 1.1.1. Criteria for Selection of Sample Providers 1) hormone receptor positive (ER+ and/or PR+) 2) Human epidermal growth factor receptor type2 negative (HER2-) 3) pN0 or pN1 is applicable 4) Female patients 1.1.2. Criteria for selecting remaining samples 1) Residual samples containing the collected tissue with paraffin (FFPE residual samples) 2) In case pathological samples that are not obstructed in future care are stored
Exclusion criteria
Exclusion criteria: 1.1.1. Exclusion Criteria for Sample Providers 1) For hormone receptor negative (ER- and PR-) 2) Human epidermal growth factor receptor type2 (HER2+) 3) pN2, or pN3 is applicable 1.1.2. Exclusion Criteria for Residual Specimens 1) Remaining samples not covered with paraffin (non-FFPE residual samples) 2) Pathologists have determined that the condition of the FFPE block is not available for clinical trials in tissue and pathology
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Disease free survival;overall survival;Breast cancer specific survival | — |
Primary
| Measure | Time frame |
|---|---|
| Distant metastasis free survival | — |
Countries
Korea, Republic of
Contacts
Public ContactJai Min Ryu
Samsung Medical Center
Outcome results
None listed